An interview with the Director of the Human Protein Atlas was recently published online in Technology Networks by the editor Molly Campbell.

In the interview, Uhlén discusses the version 22 of the HPA, which includes a new Human Disease Blood Atlas, presenting for the first time the results of a pan-cancer strategy to explore the proteome signature in blood samples obtained from cancer patients. The researchers behind the Human Disease Blood Atlas analyzed 1,463 proteins from over 1,400 cancer patients. "We highlight proteins associated with each of the analyzed cancer types based on differential expression analysis as well as a machine-learning-based disease prediction strategy. By combining the results from all cancer types, a panel of proteins suitable for the identification of individual cancer types based on a drop of blood is presented," Uhlén explains.

Link to article